Differing perspectives among gastric motility experts and regulatory roadblocks impede clinical care, but some companies are ...
Morning Overview on MSN
The Ozempic risk many users overlook: gastroparesis and more
Semaglutide, the active ingredient in Ozempic, has earned widespread attention for its weight loss results. But a growing ...
We asked four gastroenterologists which symptoms you should never ignore—and what they might signal.
A woman may only be able to eat 'a couple of Haribo' on her own wedding day after developing the 'life sentence' of a ...
Virginia hospitals, doctors and medical providers brought 1.15 million lawsuits to collect $1.4 billion in medical debt from ...
Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond ...
A woman told she did not meet the criteria to be admitted to hospital told mental health workers where she would take her own ...
Tampa Free Press on MSN
The double-edged needle: Why popular weight loss drugs are sparking alarms for EDS patients
The meteoric rise of GLP-1 receptor agonists like Ozempic and Wegovy has transformed the landscape of diabetes and obesity ...
GLP-1s are everywhere—but what’s fact and what’s fiction? University of Utah Health weight loss experts answer the most ...
A young woman who died on the M20 told mental health workers where she intended to take her own life just two hours before ...
There is a strange moment some people notice at the dining table. Hunger feels real and urgent, but after just a few bites, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results